



The risk of living with dementia and, separately, cancer, increases exponentially with age. 
However, to date, there is a paucity of research investigating the experiences of people living 
with both these conditions. This study used semi-structured interviews to explore the 
decision-making and treatment options for people who live with both dementia and cancer. In 
total 10 people living with both dementia and cancer (aged 39-93 years) and nine family 
carers were interviewed. Braun and Clarke’s (2006) approach to thematic analysis was used 
together with framework matrices to organise the data. In this article four sequential and 
descriptive themes are presented. ‘Reaching a diagnosis of cancer’ describes the vital role 
that family carers play in encouraging the person with dementia to seek an explanation for 
their presenting (undiagnosed cancer) symptoms to their general practitioner. ‘Adjusting to 
the cancer diagnosis when living with dementia’ outlines a variety of emotional and practical 
responses to receiving news of the diagnosis. ‘Weighing up the cancer treatment options’ 
highlights the different decisions and circumstances that family carers and people living with 
both dementia and cancer are faced with post-diagnosis. ‘Undergoing cancer treatment’ 
shares the finding that cancer treatment decision-making was not straightforward and that 
people living with both dementia and cancer would often forget about their cancer and what 
procedures they had been through.  
 
Background  
Dementia is a terminal and neurodegenerative condition and an umbrella term for a number 
of diagnostic variants (Alzheimer’s Society 2015). Alzheimer’s disease is the most common 
condition in both older (i.e. 65 years and over) and younger (i.e. under the age of 65) people 
(Alzheimer’s Research Trust 2010; Alzheimer’s Society 2014a,b). Currently, in the United 
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Kingdom (UK), there are approximately 850,000 people living with a dementia, a figure that 
is set to rise to over one million by 2021 (Alzheimer’s Society 2015). World-wide, 36 million 
people live with Alzheimer’s disease or other dementias (Alzheimer’s Disease International 
[ADI] 2013: 12). Increasing and advanced old age remains the most significant personal risk 
factor for developing a dementia-type illness (Alzheimer’s Society 2015) with one in four 
people over the age of 80 living with the condition (Alzheimer’s Society 2014a). The 
prevalence of dementia also intersects with gender as there are more women than men living 
with the condition and women are more likely to assume a caregiving role in the home and 
residential (e.g. care home) settings (Alzheimer’s Society 2014a; Erol, Brooker and Peel 
2016). In the UK, around two thirds of all people with dementia live at home (Alzheimer’s 
Society 2014a). Whilst there are positive experiences to be found in such situations (Nolan, 
Grant and Keady 1996; La Fontaine et al. 2016), family carers of people living with dementia 
are exposed to the greatest degree of stress and burden as compared to caregiving groups of 
any other diagnostic condition (ADI 2009).  
Dementia is usually described as transitioning through early, middle and late/advanced stages 
(World Health Organisation 2016) with people at the later end of the trajectory requiring 
support with most, and eventually all, of the activities of daily living (Alzheimer’s Society 
2014a). Whilst a  general consensus is emerging that end-of-life care for people living with 
dementia is best managed through a combination of clinical leadership, collaborative 
approaches, staff education and individualised person-centred care (Cahill, Doran and 
Watson 2012), predicting the last days of life remains a challenge (ADI 2016). Moreover, 
other than in rare instances, such as in the early identification and diagnosis of alcohol-related 
brain damage, the search for a restorative cure in Alzheimer’s disease, vascular dementia and 
frontotemporal dementia, for example, continues. In recent years, and responding to the G8 
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pledge to find a treatment for dementia by 2025, the UK has seen the development of the 
Dementia Research Institutes led by basic science with the aim of advancing understanding 
on how the dementias develop and progress (for more information, see: https://ukdri.ac.uk 
accessed 7th June 2018).  However, much work remains to be done to develop effective 
treatments that give tangible hope to people living with a diagnosis of dementia that their 
signs and symptoms can be alleviated through the use of medication alone.   
Progression through the stages of dementia is heterogeneous and prognosis is dependent upon 
a number of contextual factors, such as the: timing of a diagnosis across the trajectory of the 
condition, with an early diagnosis of dementia being a world-wide policy and practice 
imperative (Alzheimer’s Disease International 2011; see also: Department of Health 2012, 
2015, 2016); age of onset (Alzheimer’s Research Trust 2010); and the presence of any co-
existing co-morbid condition[s], such as cardio-vascular problems (Bunn et al. 2014). This 
latter context was also noted in the All-Party Parliamentary Group (APPG) on Dementia 
report ‘Dementia rarely travels alone’ (APGG 2016) which provided a salient reminder that 
around seven in 10 people who live with a dementia also live with at least one other medical 
condition. Indeed, the report’s authors made the bold, but arguably necessary assertion, that 
‘managing multiple long-term conditions is the number one challenge for the health and 
social care services this century’ (APGG 2016: 15). Worryingly, a major health policy report 
by the ADI (2016) has suggested that people living with dementia are ‘less likely to be 
admitted to hospital for interventional procedures that have the capacity to enhance quality of 
life’ (p.60) and cancer care is included in the range of conditions to which this clear statement 
of health inequality applies.  
Picking up on the previous point, the incidence of cancer is increasing annually with 50% of 
cancer diagnoses found in people aged over 70 (Cancer Research UK 2017). At present, it is 
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difficult to confirm the precise number of people diagnosed with dementia and cancer. A 
recent systematic review on this topic area by McWilliams et al. (2017) found significant 
variation in prevalence rates across a mixed evidence-base; for example, the highest 
combined dementia/cancer prevalence rates ranged from 32% to 45.6%, in United States of 
America hospice residents. In contrast, epidemiological studies report a pre-cancer diagnosis 
of dementia in cancer patients aged 68 years or older as 10% for colon, 7.4% for breast, and 
5.1% for prostate patients (McWilliams et al. 2017). This is important as cancer treatment 
decision-making is complex and clinicians need to consider a range of issues, such as the 
site/stage of disease, biological prognostic factors, patients’ performance status, 
comorbidities, social circumstances, choice of treatment modalities and potential adverse 
effects (Jalil et al. 2013). These issues become more challenging with older people given age-
related decline in physical function, decreasing hepatic and renal function, increased 
polypharmacy, comorbidities and an increase in treatment toxicities (Bridges et al. 2015). 
Moreover, the complexity of communicating information and cancer treatment decision-
making is heightened further when patients have a dementia due to the person’s potential 
difficulties in understanding, and acting upon, information about the cancer diagnosis, 
treatment options and potential risks/benefits (Taghizadeh and Österholm 2014; Smebye et 
al. 2012). Nevertheless, despite two recent reviews focussing on cancer and dementia 
(Hopkinson et al. 2016; McWilliams et al. 2017) including nine and 49 relevant studies 
respectively, no single study included during the search process explored the lived experience 
of cancer and dementia.  
Whilst there is limited social research in the field of people living with both dementia and 
cancer, an emerging body of work is beginning to appear since the two reviews were 
conducted. For example, Courtier et al. (2016) undertook a mixed qualitative methods study 
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where everyday practices for people with cancer and self-identified memory loss/dementia 
were observed across four outpatient clinics at a single UK cancer centre. The design 
included people living with memory loss with and without capacity. In the overall study, a 
total of 30 observations were undertaken between October 2014 and February 2015 and the 
final patient interview sample comprised three women with breast cancer and seven men - 
four diagnosed with prostate cancer, two with head and neck cancers, and one with a pelvic 
malignancy. Three of these patients had a diagnosis of dementia. Interestingly, from the staff 
perspective, the reliability of the informant (person with self-identified memory 
loss/dementia) and their ability, or otherwise, to comply with complex treatment regimes, 
became crucial issues in the treatment process. Accordingly, carers were reported in this 
study as being the ‘key facilitators’ for successful cancer consultations and management. 
Paradoxically, the authors then reported that the support needs of such carers were largely 
unrecognised and that staff were uncertain as to how to communicate effectively with 
patients who had memory difficulties (see also: Trachsel, Hermann and Biller-Andorno 
2015). 
This uncertainty and power imbalance in clinical decision-making in cancer care was also 
identified in an Australian study by Cook and McCarthy (2018). Here, Cook and McCarthy 
(2018) interviewed nine key staff members in a large cancer service and one of their key 
findings was that clinicians associated dementia with ‘a lack of competence to understand the 
information provided’ (p.9). A similar conclusion was reached in an exploratory UK study by 
Witham, Haigh and Foy (2014) where healthcare workers from a regional oncology centre in 
the UK positioned people living with dementia and cancer as a vulnerable group but were 
uncertain as to what to do if vulnerability was identified and how it may then impact on their 




To help further inform the field, this article attempts to build on this emerging literature by 
extending the numbers of people who live with both dementia and cancer and their family 
carers (where possible) within a qualitative study design and provides an exploratory 
thematic representation of lived experience. This article addresses the two following 
questions: i) ‘What is it like to live with dementia and then adjust to the experience of also 
living with cancer?’ and ii) ‘How are people who live with both dementia and cancer then 
involved in treatment decision-making, which may have curative potential for cancer?’  
 
Methods 
Participants and setting 
A qualitative design using semi-structured interviews was used to explore the cancer and 
decision-making experiences of people who live with both dementia and cancer and their 
family carers. The study was set in a regional cancer centre (tertiary care) in North West 
England serving a population of 3.2 million people. Purposeful sampling was used to identify 
participants with a confirmed dementia diagnosis known to the Macmillan dementia nurse 
consultant based at the hospital [LB in the authorship]. LB was also able to give any 
additional support to participants should there be any distress from involvement. In the event, 
this was not called upon. Inclusion criteria were patients with: a) any cancer type, b) any 
stage and type of cancer treatment and c) any dementia type and severity. Family carers (if 
any present) were eligible to take part after the patient’s consent had been confirmed; 
however, patients were able to participate should the family carer subsequently decline to 




Prospective participants were approached by the Macmillan dementia nurse consultant (LB) 
who provided written study information and requested permission for one of the research and 
authorship team (LM) to initiate contact and answer questions about the study. As the 
research team were keen to involve people with dementia across the trajectory of the 
condition, the study followed the procedures prescribed by the Mental Capacity Act 
(Department of Health 2005) for involving those who may lack capacity to consent. These 
procedures were operationalised through the guidance supplied by the British Psychological 
Society (2008) which helps researchers to comply with the nuances and requirements of the 
Mental Capacity Act (Department of Health 2005), particularly on consent and recruitment 
into a study. As such, if it was deemed that a person with dementia lacked capacity to consent 
to the research then personal consultees were provided with information about the study. In 
the reported study, all personal consultees were family members who gave permission and 
written consent to the research team to approach the person with dementia about their 
involvement. If the person with both dementia and cancer subsequently consented to 
participate, their family member was also invited to take part in the study before making the 
necessary interview arrangements.  
Interviews were conducted face-to-face in a quiet hospital room or in the patient’s home. 
With consent, interviews were audio-recorded. Patient participants were given the choice of 
completing their interview alone or with a family carer. Family carers could support the 
patient interview and/or have a separate interview with one of the research team. 
Demographic and clinical information was collected from the medical notes, for example age 
and cancer treatment information. An interview topic guide was developed and questions 
focussed on the experience of both dementia and cancer which included signs and symptoms 
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of cancer, experience of diagnosis, treatment decision-making and cancer-related information 
needs. All but one [CF] of the interviews was conducted by LM, both postdoctoral 
researchers with experience of qualitative methods, continually discussing emerging findings 
and conceptual codes with co-authors. The sample of people who live with both dementia and 
cancer and their family carers is a sub-set of a larger study conducted by the authorship and 
reported elsewhere (McWilliams et al. 2018).  
Sample 
As shared in Table 1, the sample included people who live with both dementia and cancer 
(n=10) and family carers (n=9). All but two people who live with both dementia and cancer 
had a family member participate (plus two family members participated for one patient). Two 
people who lived with both dementia and cancer had capacity to give informed consent, and 
proxy consent was provided by a family member (personal consultee) for eight patients who 
lacked capacity. Verbal consent from the person living with dementia was received before 
any study procedures began. One other patient who lived with both dementia and cancer was 
invited to participate, however the personal consultee did not consent for the researcher to 
approach the patient because of the patients’ communication difficulties. 
Of the eight audio-recorded patient interviews, five took place as a dyad and ranged from 46-
62 minutes; patient alone interviews (n=3) lasted 10-35 minutes. Family carer interviews 
lasted 26-49 minutes. Cancer disease groups included head and neck, colorectal, urology, 
skin, gynaecology and haematology. Nine patients had a pre-existing dementia diagnosis 
prior to attending the cancer hospital; one received a diagnosis of Alzheimer’s disease during 
cancer treatment and was interviewed following completion of treatment. Other dementia 
diagnoses included Pick’s disease, vascular and AIDS-related dementia. Patients had been 
exposed to a range of cancer treatments including radiotherapy, surgery, palliative 
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chemotherapy and stem cell transplant. For one patient in the study sample, treatment was on-
going and for another, a best interests meeting had taken place for the person who lived with 
both dementia and cancer to have no cancer treatment at all. This will be returned to later in 
the article. 
 
INSERT TABLE 1 ABOUT HERE 
 
Data Analysis 
Interviews were audio-recorded, anonymised and transcribed verbatim; field notes were taken 
for each participant case (two patients refused to be audio-recorded and field notes were 
taken only). The data were analysed using Braun and Clarke’s (2006) thematic approach and 
by means of framework matrices to organise the data, which allows for case comparison. 
Each transcript was read by a smaller analysis team [LM, SB, CS, JK] to get an overall sense 
of the data pre-coding. An agreed set of codes for the person who lives with both dementia 
and cancer and family carers were entered into the framework matrix for each of the two 
participant groups. On-going analysis and its interpretation were discussed at research 
management group meetings [i.e. all members of the authorship] when alternative 
explanations for emergent findings were suggested and discussed. The analysis focussed on 
information needs and decision-making in the context of people who live with both dementia 
and cancer. 
Data are presented as four overarching themes: i) Reaching a diagnosis of cancer; ii) 
Adjusting to the cancer diagnosis when living with dementia; iii) Weighing up the cancer 
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treatment options; and iv) Undergoing cancer treatment. All names appearing in the article 
are pseudonyms and the study received appropriate ethical approval (Ref: 16/YH/0156).   
 
Findings  
Theme 1: Reaching a diagnosis of cancer  
Most family carers and people living with dementia spent a significant amount of time in the 
interview reflecting about how their, or the person living with dementia’s, diagnosis of cancer 
was made. As the diagnosis of cancer for the majority was made at a point in time prior to the 
visit to the cancer treatment hospital, across the data set, responsibility for making a decision 
to attend the individuals’ GP to investigate the presenting adverse physical symptom(s) was, 
in most cases, initiated by the family carer. For example, in case 2, Brenda’s husband, Steve, 
described himself as ‘doing some detective work’ having noticed that his wife was attempting 
to hide her rectal bleeding. As Steve went on to explain, the bleeding was present and 
noticeable in his wife’s underwear, which he regularly placed in the couple’s washing 
machine as part of his everyday caring duties. However, whilst Steve initially thought that 
this occurrence was ‘odd’ he did not immediately seek help from their GP for some six 
months as he thought that the bleeding was ‘a woman’s thing’ and that  it would ‘simply 
stop.’ Only the continuation of the bleeding and soiling over time led Steve to believe that 
something more serious was happening and the couple’s GP consulted. This step eventually 
led to the diagnosis of colorectal cancer.  
Similar ‘detective stories’ were shared by other family carers in the sample with Billy (case 
9) believing that his mother’s dementia played a significant role in the length of time it took 
to seek help, as he explained:  
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‘I still think it could have been spotted earlier on but it wouldn’t have been so easy to 
spot with her picking it … which I think might have been through the dementia.’ 
However the decision to explore the presenting symptoms was reached, all participants living 
with dementia in this study were referred to the specialist cancer centre for further tests and 
investigations and, ultimately, faced with decisions about cancer treatment. At this point, the 
data shared some interesting insights into the procedures and practices that took place and 
how the experience of living with dementia intersected with the clinical test procedures. 
These diagnostic investigations take place most often at secondary care district hospitals 
before attending the cancer treatment hospital. For instance, Steve (case 2) stated that his 
wife’s diagnosis of dementia may have actually helped her to cooperate during what were 
intimate diagnostic investigations for colorectal cancer as, prior to her diagnosis of dementia, 
Brenda’s main coping pattern over her life course had been to ignore problems and hope that 
they would go away. Steve, therefore, put his wife’s self-styled acceptance of the situation 
down to a ‘blunting caused by the dementia’ and a belief that ‘the awareness wasn’t really 
there of what was involved ... she just went with it and didn’t seem at all worried.’ It was 
clear that Steve displayed a strong sense of responsibility for assisting both the healthcare 
practitioner and his wife during the course of her clinical investigations: 
‘We had a lot of problems with her [Brenda] not keeping still during the scanning 
stages. We had one scan aborted and she wants me in the room with her to reassure 
her. There was a real need for me to be there at every point and every stage.’  
The situation was made more problematic as Steve felt that the healthcare practitioner gave 
his wife ‘very complicated instructions’ during the cancer investigation phase. This simply 
fuelled Steve’s need to be in the same space and time with his wife ‘to break those 
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instructions down into basic things’, as he succinctly put it. Understandably, this was not a 
situation where patient privacy and confidentiality could be placed centre stage.  
In addition, Darren (case 4), reflecting on his wife’s investigative procedures at a secondary 
care hospital, suggested that healthcare practitioners were not always confident in 
communicating with patients who had a dementia and made the telling observation that: 
‘She had not a clue that nurse. She kept blaming her [Joan, person living with 
dementia] for moving but she didn’t move. I don’t think they [healthcare practitioner] 
realise that she wants somebody with her when they’re doing something. She wants 
somebody with her, rather than just staying in here [the clinical investigation room]. 
She’s getting upset the whole time, waiting ... [pause] ... but anybody like her, I don’t 
think they explain things properly. They don’t realise that they [people living with 
dementia] can’t take everything in. Not properly. They just told her what they told us.’  
Explanations about the steps necessary to reach a diagnosis of cancer were central to families 
as they were often uncertain about the process of taking consent for clinical investigations 
from someone who had a dementia. This uncertainty extended to knowing how much, or how 
little, they were to be involved in the clinical investigations consent process of their relative 
with dementia and what level of responsibility - if any - they shouldered in taking such a 
decision. Returning to Darren’s (case 4) experience, he believed that the healthcare 
practitioners did not consider Joan’s dementia to have any influence on her ability to 
understand and sign consent forms for procedures that she was about to undergo. However, 
this stood in stark contrast to his own understanding of this situation, a position drawn down 
from caring at home for his wife and knowledge of her cognitive functioning. Indeed, from 
the research team’s perspective, and as Table 1 illustrates, Joan lacked the capacity to consent 
to an interview and required the personal consultee [Darren] to make that decision for her. 
13 
 
Managing steps to involvement and inclusion was important. As a person living with 
dementia, the language Joan (case 4) used to explain her understandings and reflections about 
the biopsies that were continuing to take place post-diagnosis of her bowel cancer, was 
illuminating:  
‘That woman who ran around and hurt me. Well, she didn’t know what she were 
doing. “No!” I kept saying to her. I said “It’s not right!” Two people hit at me. Well, 
I had to go onto, you know ... [pause] ... and eh, I don’t, I weren’t bothered about 
doing it ... [pause] ... but when she started, you know, she was ... [pause] ... at me 
weren’t she? [turns to look at husband].  So I was ... what’s her name about that?’  
Whilst Joan’s narrative may be fractured, the inherent meanings of her remembered and 
understood experiences can be clearly distilled from the words that she used to reflect on her 
clinical investigations. Moreover, the black-and-white words on this page do not do justice to 
the inflected emotions contained in some of the phrases (e.g. ‘two people hit at me’) and 
embodied movements that Joan performed during the telling of her story, such as contorting 
her face at certain points in time and (seemingly) wringing her hands with worry. For Joan, 
the shared and remembered stories were all about the pain and distress in undergoing highly 
personal and intimate clinical investigations. A similar experience was faced by Steve (case 
2) who shared that his wife, Brenda, would often ask staff ‘if they were going to put a camera 
up her bottom.’ Whilst such clinical investigative procedures were undoubtedly necessary, 
they provided moments of experience for people living with dementia where the meaning of 
the clinical intervention was not always understood at the time or remembered in a way that 
tied the clinical act to a helping procedure. 
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Across the data set, for people living with dementia, it was the physical and emotional pain as 
well as personal invasion that seemed to hold most sway in the remembering and in the 
telling.  
Theme 2: Adjusting to the cancer diagnosis when living with dementia 
The dataset also displayed a variety of responses to receiving the cancer diagnosis by people 
living with dementia. For example, Ben (case 6), who received a diagnosis of head and neck 
cancer, reflected on the biographical connection of his diagnosis to that of his father who had 
also received the same diagnosis some years previously. However, Ben’s father was not 
living with dementia at the time. As Ben shared during the interview, his father’s diagnosis of 
head and neck cancer, and his eventual death, was ‘a horrible time’ in his life and this 
negative event, and association, affected him profoundly when he received exactly the same 
cancer type diagnosis. Ben made sense of this very challenging situation by acknowledging 
‘the relief’ that he felt in the improvements in cancer treatment and care in the present day as 
compared to his father’s time. Other ways of adjusting to the cancer diagnosis when living 
with dementia included June (case 1) who thought the ‘whole thing was barmy’ and that 
‘you’ve just got to get on with it.’ A search for normalising everyday life appeared an 
important sense-making driver in such circumstances.  
On the other hand, some family carers believed that the person they were caring for was 
either unaware that they had received a diagnosis of cancer or had simply forgotten what it 
was that they were told. As an illustration, Joe, Sally’s son and family carer (case 3), shared 
the following observation:  
‘The doctor informed her [Sally, person living with dementia] that it was head and 
neck cancer … well, she wasn’t shocked at all or anything about it.… [pause] … but 
then, I don’t think she understood what the doctor was saying or what she had.’  
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In an attempt to help his mother understand the seriousness of the diagnosis, Joe used the 
doctor’s words at the time of the diagnosis when he communicated to Sally that she had a 
‘dirty throat.’ It was rehearsing and reinforcing this direct correlation between the words 
‘dirty throat’ and ‘cancer’ that Joe hoped his mother would understand and therefore identify 
with the seriousness of her situation. This creative strategy worked up to a point with Joe 
explaining that his mother remembered on a few occasions that ‘she has cancer’ but then ‘she 
lapses and it reverts back to really not knowing what’s up with her.’ Adjusting to a diagnosis 
of cancer when living with dementia had the potential, therefore, to not be a once-only event 
with families, and those with the diagnosis more specifically thrust into a fluctuating cycle of 
awareness and unawareness of disease states. Building on this point further, Alistair’s cancer 
diagnosis (case 9) was unexpected despite a lengthy period of investigations for various 
health-related illnesses, as described by his wife Maria: 
‘We got report after report, he’s just ‘an elderly man’ and they couldn’t find anything 
particularly wrong. I was very surprised to find that we were seeing the [cancer] 
specialist … [pause] … I was expecting something, but not that. When you’ve gone in 
thinking you are looking at a hernia … it comes like a bolt from the blue.’ 
During the interview, Alistair was unable to share his view on having cancer but it was clear 
that the diagnosis had caused a significant disruption to family functioning and adjustment, 
with Maria requiring a great deal of time during the interview to help her to share their story.  
Such relational disruption carried through to the next theme, weighing up the treatment 
options, as the diagnosis of cancer, and its aetiology and prognosis, demanded further 
decisions to be taken by those at its centre: the person living with both dementia and cancer 
and their family member, informed by the cancer specialists and the healthcare practitioners. 
Some of these decisions were to be taken immediately, some could be taken over time and 
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some decision options were left open to have no treatment at all. For participants, each of 
these outcomes had their own states of emotional upheaval which varied from person to 
person and family to family.  
Theme 3: Weighing up the cancer treatment options 
Just as in dementia where the diagnosis acts as a critical juncture between a pre and post 
diagnostic identity (i.e. the diagnosis transitions you from a person without to a person with 
dementia and all the challenges that this label can then embody), the same reality exists in 
cancer, as seen in the previous theme heading. However, unlike in dementia, once a cancer 
diagnosis is made there are surgical interventions and medications that can potentially stem, 
reverse and cure the condition. Not for all cancers and not at all stages of a cancer diagnosis 
of course, but there is hope that the individual living with a diagnosis of cancer can return to 
a previous identity of being cancer-free and hold a future identity of being a ‘cancer survivor’ 
- an identity that engenders considerable compassion in society.  
This potential to return to a healthy state from a diagnosis of cancer instigated the next step in 
the adjustment process, namely weighing up the cancer treatment options. This was not a 
straightforward process and many mentions were made of the word ‘time’ throughout the 
interviews when people who live with both dementia and cancer, and their family carers, 
were deciding what to do next. For instance, oncology doctors were asked to both ‘slow 
down time’ and ‘to take more time’ when offering choices in how to treat the cancer. As an 
illustration, Molly (case 6) wanted more time in the treatment option discussions as she had 
taken on the role of the ‘relayer of information’ [Molly’s description] to her father, Ben, who 
had a diagnosis of head and neck cancer and Alzheimer’s disease. As Molly explained: 
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‘That treatment consultation was really fast for me ’cause they talk really, really fast 
[laughing]. It’s just fast and it’s quick. This is a busy place for somebody with 
dementia. It all needs to be slowed down so much more.’ 
The importance of pacing and giving time to others was also seen in Maria’s (case 9) 
explanation of the treatment decision-making process for her husband with metastatic cancer 
and stood in contrast to all other accounts in the data set:  
‘He [consultant oncologist] went through everything with Alistair and said “you don’t 
have to make a decision now, you can decide, you know, decide in your own good 
time because I realise this has come as a, as a big shock to you, you weren't expecting 
it, and I wasn't expecting to be recommending this to you.’’ That was a real help.’ 
Maria went on to explain that the consultant repeating the information and cancer treatment 
options to her husband ‘several times’ was a good strategy, as well as simply sitting down 
next to him and losing the ‘airs and graces.’ 
Time was also referred to by people who live with both dementia and cancer and family 
carers when discussing the format and quantity of cancer treatment information provision 
prior to treatment decision-making. As an illustration, Steve (case 2) felt that he received 
enough verbal and take home information (in the format of leaflets for instance) about the 
various procedures for treating Brenda’s colorectal cancer and found it helpful that his wife 
was present during all these discussions, although more in the shape of passive rather than 
active involvement. This rather lengthy extract from Steve’s interview transcript best 
illustrates this conundrum:  
‘She was there with the doctor here … and she was, you know, part of that discussion.  
But again, you know, with her dementia, she was more interested about talking to the 
18 
 
registrar, whether he was married or not. You know, did he have any children? Her 
mind wasn’t … the attention span and the focussing on something very, very 
important about someone’s health just wasn’t of much concern to her really. Although 
she was throughout the whole of the consultation, you know, there being informed of 
what the diagnosis was and the treatment plan. She was just not particularly, you 
know, focussing on that. She was more concerned with whether or not someone was 
married or what football team they liked and things like that, because of the 
dementia.’ 
Participants also discussed the format of information that they received about treatment. 
Darren (case 4) felt that he had to seek information out for himself to support the decision-
making for his wife. Ben (case 6), as a person with dementia and a recent diagnosis of head 
and neck cancer, felt that the cancer treatment information had to be offered in a variety of 
ways and formats with time given to ensure that he knew what was about to happen, or could 
happen, as he shared in this telling observation:  
‘All that was spoken about I took in.  But they [had] given us these leaflets; they had 
to be read for me … ’cause I just can’t do it and sometimes I know that but I just can’t 
do it.’ 
Interestingly, for Ben’s daughter Molly, the length of time and speed of consultations were a 
concern as the contents had ‘gone over my head a bit’ and that she wanted more written 
information or the opportunity to have time to write things down herself, so that she could 
take her time and pass the information over to Ben in a way that he could ‘take it all in.’ This 
is an important point as Ben later clarified that his listening and understanding were 
situationally positioned ‘in the moment’ and that after a few minutes, he would simply be 
unable to recall what had been said. A state of affairs he also associated with the research 
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interview that was being conducted at that moment in time. The exchange also speaks 
volumes about the central role of the family carer, their longitudinal and biographical 
knowledge of the person with dementia and ‘trial and error’ expertise in effective 
communication approaches.  
For some participants, decisions about the treatment options were immediate and clear-cut as 
Victor (case 8) shared in this straightforward summary:  
‘You can get bombarded with irrelevant information … and then it all becomes too 
much. I think to some extent I pushed all the negative things out-of-reach because the 
alternative is … [pause]… was worst.  Yes, there were risks of having the treatment 
[post stem-cell transplant] but there were risks in not having the treatment as well.’ 
The role of the family carer was central to weighing up the cancer treatment options and was 
prompted by people living with dementia being aware that they would forget. It was time 
precious in other words. As Victor went on to explain ‘I felt as though if the doctor came to 
me and outlined what my problems were I’d forget that information.’ Joseph (case 5) also 
found the prospect of involving other supporters of the person living with dementia in the 
consultations helpful, as he shared:  
 ‘I can forget a few things and not ask the correct questions … it’s good for somebody 
here [points towards nursing home staff office] to go with me. So having a person 
there makes a lot of sense. They can repeat everything that’s been said … back-up.’  
This need for the person living with cancer and dementia to protect themselves from the 
potential of mis-remembered - or forgotten - consultations about their cancer treatment was 
ever-present and caused heightened personal anxiety, particularly when focussed on the risk 
of complications due to the cancer treatment. A potential solution to this dilemma was put 
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forward by Victor (case 8) when he suggested that a triadic consultation between: the person 
living with both dementia and cancer – healthcare practitioner – family carer should be 
considered ‘the norm.’ However, Victor expressed concern about how people living with 
both dementia and cancer, who lived alone, might cope should they find themselves ‘in the 
same situation as me.’ 
One of the most difficult issues in weighing up the cancer treatment options came about when 
the interaction between symptoms of dementia on cancer treatment tolerance, and possible 
progression of the dementia, was discussed by participants. In the dataset, this manifested 
mainly in the conversations held by healthcare practitioners and family carers, rather than by 
the person who lives with both dementia and cancer him or herself. The potential for these 
interactions to occur in real-time significantly influenced the decision for Agatha (case 10) 
not to have cancer treatment as Agatha’s son, Billy, described:  
‘We could end up with somebody being maybe cured of a cancer but a lot worse on 
the dementia, so that's something we didn't want. Have an operation and they come 
out a lot worse it all seems so ... pointless.’ 
For both carer and oncology doctors in this case, quality of life was the most important 
decision-making factor for Agatha and that time, the best interests meeting was invaluable in 
successfully navigating through the decision-making process. However, for Billy, the 
decision not to treat left a lasting legacy as he shared in these reflections on his mother’s best 
interests meeting:  
‘I don't think she was too aware at the meeting. She was there but not really that 
involved. I don’t think she understood what was going on really. She’s not understood 
the full implications but did have a chance to comment if she wanted to. My mum did 
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have a chance to say something, but I think she was messing with someone’s hair at 
the time.’ 
 
Theme 4: Undergoing cancer treatment 
This final theme considers the experiences of the person living with dementia undergoing 
cancer treatment and what rose to the surface as important areas to consider. Alan (case 7), 
for example, found it difficult to remember his cancer surgery although he was able to talk 
with more certainty about the healthcare practitioners who attended to his post-surgical 
dressings. On the other hand, Alan made a plea for staff consistency in the process as all the 
‘swapping about’ only added to his ‘confusion’ [Alan’s word]. Similar to the creative use of 
word association used by Joe (case 3) to his mother (i.e. ‘dirty throat’ = cancer diagnosis) 
earlier in the article, he continued this technique in preparing his mother, Sally, for a set 
course of radiotherapy for her head and neck cancer as this rather moving extract from the 
data reveals:  
‘They told her [Sally] what was going to happen. They did the various tests with us 
where they put little bits on her [mask fitting for radiotherapy treatment]. I can’t 
remember, they had like a …  just put a bit of it, like a bit of this stuff on her face so 
she could feel what it was like, and then explained it, like a wet flannel, a warm 
flannel; so again that’s … that has sunk into my mum’s head about a wet flannel. So 
all the treatment, when she had this mask on each day, the only one thing that she 
always remembers - if you ever ask her - she always remembers the wet flannel. She 
won’t remember anything if you say “Well, you’re having this mask on’’ she’d be 
oblivious to it really, but if you say “Mum, remember the flannel? You’re having this 
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flannel back” and then she’d remember. I don’t know why that is, but obviously they 
had to sedate her with a tablet to calm her down to have it done.’ 
For Joe, his mother’s prolonged course of radiotherapy treatment (i.e. physically attending at 
a radiotherapy unit daily for four weeks) placed demands outside of his usual caring role. Joe 
also had a job and he was thankful for the understanding and support of his employer in 
allowing him to be with his mother during her period of radiotherapy treatment.  
Recalling major investigations and clinical procedures was also apparent in Alan’s case (case 
7). For example, Alan found it difficult to remember the surgical procedure he had undergone 
to remove the skin cancer from his leg as this exchange with the researcher (LM) reveals:  
Lorna: I would like to ask you how you feel about your leg. 
 
Alan: About what? 
 
Lorna: Your leg. 
 
Alan: What about it? Alright … Why? What’s up with it? 
 
Receiving cancer treatment also caused significant difficulty for participants living with 
dementia in other ways. For example, Alistair (case 9) was admitted as an emergency to 
different hospitals on two occasions part-way through his out-patient treatment. His wife, 
Maria, felt that this was due to the cancer treatment (chemotherapy) and its unanticipated 
side-effects. More importantly, perhaps, Maria viewed the experience as being ‘very difficult 
for them both’ as the initial hospital admission (secondary care) heightened her husband’s 
confusion and levels of disorientation, as she explained:  
23 
 
‘He didn't know where he was and he didn't know who the people coming in were. He 
became terribly anxious and kept talking about things over and over. It was not a 
pleasant experience at all and in the end he came home probably before he should 
have done. I don't know ... I just couldn't bear him being in there anymore. So I 
brought him home with very little help, fast-track sort of thing, and they provided 
some carers to come.’  
Despite this, Maria reiterated how determined Alistair had been to eventually continue with 
chemotherapy treatment although, unfortunately, during the interview, Alistair was unable to 
reflect on the experience himself at that moment in time.  
Continuing the theme of re-contextualising words and experiences so that people living with 
dementia were able to hold on and make sense of them, Sally (case 3) named the hospital - in 
which she had been a patient for several months - as ‘the big white house.’ Through this more 
familiar and domestic analogy, Joe spent time reflecting on whether or not his mother’s 
radiotherapy treatment for cancer had exacerbated her symptoms of dementia, as he shared:  
 ‘I don’t know whether or not the drugs were having the impact on her as well; so it 
was the dementia with the impact of the drugs and all that together, having this 
change of the way my mum seemed. There’s been a massive change with my mum 
dementia-wise.’  
Interestingly, the space created by undergoing treatment for the cancer gave an opportunity 
for family members to consider future options and if a return home for the person living with 
cancer and dementia was the best thing to do. This was neatly summarised by Joe when he 
said that his mother’s cancer treatment was a ‘blessing in disguise’ as prior to the admission, 
he felt that it was best for his mother to go into a care home because of her dementia, but this 
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had been [understandably] resisted. Now, with the cancer diagnosis and further advancement 
of his mother’s dementia, the situation had progressed to a point where a future placement 
decision was seen as being in Sally’s best interests. A similar ‘best interests’ decision was 
also reached for Brenda (case 2) when she was to be discharged from hospital to a care home. 
This is not to be construed in any way at all as a criticism of the family and health/social care 
practitioners involved in either Sally or Brenda’s situation, but, rather, as a reflection of the 
reality of the transition from NHS hospital bed to care home admission that is a reality for 
many people living with dementia in such circumstances.   
Finally, the data identified a reflective component attached to undergoing cancer treatment 
for people living with dementia. As an illustration, Victor (case 8) stated that whilst he is now 
feeling ‘more well’ after his stem-cell transplant, he was starting to consider the lasting 
implications of his dementia diagnosis on his everyday living and the experience he had just 
been through, as he stated:  
‘Trouble is I don't remember much about all this. I’m still recovering so I’m more 
aware of problems … I’ve come home and having to adapt and things in the house or 
re-learnt things which I’d forgotten about because I’m getting better I see what’s 
wrong with me more. I’ve come home and having to adapt ... just trying to find where 
the light switches are.’  
In contrast, Joan (case 4) said that she didn’t think she would like to go back to the hospital as 
she remembered the pain attached to her previous cancer-related experiences. 
Finding ways of continuing to support an understanding of the procedures and processes that 
people who live with both dementia and cancer had endured seems such an important future 
step as the remembered experience of the person may be lost or its narrative meaning broken 
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and/or fractured, as seen in shared extracts of data. Indeed, however the diagnostic and 
treatment stories are told by the person living with both dementia and cancer is an accurate 
record for its narrator and, as such, its meaning(s) should not be lost, diluted or discounted by 
families and/or by healthcare practitioners searching for ‘the truth’ of authentic 
representation. Arguably, locating ways to bridge that divide becomes a central goal of 
treatment in patients living with both dementia and cancer and in navigating and negotiating 
future treatment pathways.  
 
Discussion  
This study explored the lived experience of 10 people living with dementia who had received 
a diagnosis of cancer and nine family carers. This included understanding how people who 
live with both dementia and cancer adjusted to their particular life circumstances and their 
specific cancer type, as well as developing a clearer insight into treatment decision-making. 
Of the 10 participants living with both dementia and cancer in the study, only two were able 
to give informed consent to participate, the other eight requiring the involvement of a 
personal consultee to facilitate involvement, as per the study protocol (see also: British 
Psychological Society 2008). Whilst measuring the neuropsychological performance of 
participants was not part of the study design, as we relied instead on the clinical diagnosis of 
dementia already being made prior to the person being referred into the study, the number of 
consultee permissions required to conduct the interviews does suggests that issues of capacity 
framed the study analysis and influenced the outcomes of the work. 
Perhaps this was seen most vividly in the data set when Billy (case 10) described his mother’s 
lack of engagement in her best interests meeting with the words ‘she [Agatha] was messing 
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with someone’s hair at the time.’ In other words, despite the seriousness of the multi-
disciplinary team meeting and the focus on cancer treatment decision-making that was taking 
place, Agatha was simply unable to follow the prescribed social cues and engage in real-time 
with the events that were being discussed around - and about - her. As seen in Table 1, the 
outcome of the best interests meeting was for Agatha not to have any treatment for her 
cancer. This leaves an uncomfortable question: was this decision-making just? 
Given the recent focus in the health and social policy literature on acknowledging the human 
rights of people living with dementia and in making transparent how people living with 
dementia are involved in decision-making (Mental Health Foundation 2015), it may be that 
enhanced legal protection of the person with dementia moves to the forefront of ethical 
practice and clinical/treatment discussions building on the platform provided by the Mental 
Capacity Act (Department of Health 2005). Moreover, people living with dementia 
themselves are actively pushing forward this rights-based agenda with active plans to nest 
their rights within the United Nations Convention on the Rights of Persons with Disabilities 
(CRPD; Dementia Alliance International 2016) where the general principles of the 
Convention cover: respect for dignity, autonomy, freedom to make choices, independence; 
non-discrimination (disability, gender, ethnicity, age); full participation and inclusion in 
society; respect for difference; acceptance of disability as part of human diversity; equality of 
opportunity; accessibility; and gender equality (p.10). As such, and given the lack of 
published guidance, it would seem timely for future care pathways that address the needs of 
people who live with both dementia and cancer to be underpinned by these general principles. 
Moreover, whilst interventions to improve healthcare staff training and education in treatment 
decision-making are available in the generic cancer-care literature (see for example: Henoch 
et al. 2013) so far, none has been identified in the area of living with a diagnosis of both 
27 
 
dementia and cancer. This is despite the importance of the topic area seen in this and in recent 
studies and the need to enhance clinical practice and patient outcomes (see for example: 
Courtier et al. 2016; Cook and McCarthy 2018).   
Whether the issues around capacity found in this study, albeit with a limited sample size, is 
indicative of a longer time to diagnosis of cancer when people also live with a dementia, is 
speculative. However, a recent review of the dementia and cancer literature by McWilliams 
et al. (2017) identified two studies where the diagnosis of dementia influenced suspected 
cancer referrals and subsequent cancer treatment, or otherwise. One retrospective study 
investigated the influence of dementia on cancer referrals and found that out a sample of 121 
doctors, 33% chose not to refer nursing home residents with suspected breast cancer for 
diagnostic testing and anti-cancer treatment - the primary reason cited was a diagnosis of end-
stage dementia - yet only 41% of decisions were discussed with the patient (Hamaker et al. 
2012), perhaps underlining the importance of adopting the CRPD going forward. In the 
second study, recommendations for improving the care of patients with dementia and cancer 
were reported in a small qualitative study involving five healthcare professionals. 
Interestingly, prime amongst these findings was the need to, firstly, provide support for 
family carers to enhance their involvement in decision-making and, secondly, to help 
ameliorate the family carer’s emotional frustrations due to the communication difficulties 
often associated with dementia (Bartlett and Clarke 2012); a situation that echoes the 
experiences of Billy (case 10) and the majority of the family carers in this study. Additional 
research into the prevalence and lived experience of people who live with both dementia and 
cancer, and health professional’s decision-making and management responses, particularly 
when the cancer is terminal, would appear necessary to help provide a more transparent local, 
regional and national picture.  
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Caregiving is a gendered experience and in the reported data set, five men and four women 
comprised the study sample of family carers of people who live with both dementia and 
cancer. However, with some notable exceptions (see for example: Mc Donnell and Ryan 
2013), gender has been largely overlooked in the dementia studies literature especially in 
regards to care being provided at home (Erol, Brooker and Peel 2016). This omission has 
consequences. For example, in theme 1, reaching a diagnosis of cancer, the active social 
process of ‘doing some detective work’ appeared to eventually push Steve (case 2) into 
finding out what caused the bleeding he regularly encountered in washing his wife’s 
underwear. Steve had cared for his 60 year-old wife, Brenda, for a number of years following 
her diagnosis of Pick’s disease, a type of frontotempotal dementia. Given Brenda’s age it 
was, perhaps, fully understandable for Steve to rationalise that the blood in wife’s underwear 
was due to menstruation, or the onset of the menopause or, in Steve’s more perfunctory 
words, ‘a woman’s thing.’  
The example above is a salient reminder that care is conducted at an emotional level but it is 
performed on, through and with the body. A few years ago, The International Longevity 
Centre - UK (ILC-UK) wrote a report entitled ‘The last taboo’ and focussed its discussions 
around sexual behaviour and intimacy in care homes (ILC-UK 2011). Whilst such attention is 
important and necessary, the title of the report was unhelpful as there are many caring taboos 
in dementia (and outside of this condition too of course) and one of them is in understanding 
more about the intimate care provided by men to their female spouse/partner with younger 
onset dementia during menstruation. The field in dementia care is awash with studies that 
address the importance of information in care, but it is not so plentiful in understanding the 
bodies of the person being cared for. Knowing more about the female body may, and we 
stress may, have helped Steve pathologise the encountered bleeding earlier in its onset and 
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seek help sooner than the six months that it took him. This was not a recognition of the 
trajectory of dementia and the onset and management of behaviours that challenge (Moniz-
Cook et al., 2017), for example, but, instead, it was one of recognising the early signs of anal 
(colorectal) cancer - a situation complicated by the fact that Brenda was simply unable to 
verbally share her concerns about her body with her husband. Individualising, and improving, 
the breadth and depth of information to family carers of people living with dementia to 
include the onset and signs of other long-terms conditions would be a suitable starting point 
to help improve the situation.  
Linked into the above point is the need to develop information-giving support that is 
constructed from the language and meanings of care that are recognisable to those 
undergoing the process. This was seen in the data by Joe (case 3) explaining his mother’s 
cancer to her as a ‘dirty throat’ and then aligning his mother’s course of radiotherapy 
treatment for her head and neck cancer to a ‘wet flannel’ so that she [Sally] could better 
understand the treatment that she was about to undergo. Staying with this family, it was also 
revealing that Sally (case 3), as a person living with both dementia and cancer, named the 
hospital where she had been an in-patient for cancer treatment for several months as ‘the big 
white house.’ By reflecting on these narrative constructions, these experiences are about 
making sense of the everyday and testing out, and adopting, communication strategies that 
worked for those involved, however painful the events. Arguably, it becomes necessary to 
leave space in professional caring practices for creativity and inventiveness in 
communication strategies between those who live with the condition and those closest to that 
person to help inform treatment approaches, decision-making and care documentation. As 
Richards (2007) has noted, this everyday creativity is not trivial and ‘represents a pervasive 
and dynamic way of being and knowing, and of encountering the world' (p.48). By embracing 
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this ‘little-c’ approach to creativity (Kaufman and Beghetto 2009; Bellass et al. 2018) it 
would, potentially, result in new ways of thinking about support, its meanings, embodiment 
and measurement, but driven from the life-world of those undergoing its impact. And that’s 
the crucial point, especially when people living with dementia are attempting to make 
decisions and sense of the world around them through a limited palette of communication, 
spatial and remembering abilities.  
Finally, to help advance understanding and public awareness, it would be important for 
people who live with both dementia and cancer to provide additional testimonies about their 
experience. As seen in the sample for this study, the ages of people who live with both 
dementia and cancer ranged from 39 to 93, but with the majority being over 70 years of age – 
which is reflective of the national picture. Finding ways to facilitate and empower such 
diverse ages and experiences is a daunting but, arguably, necessary challenge and one which 
can only help unlock opportunities to enhance the quality of life and well-being of people 
who live with both dementia and cancer. Such an approach would also assist in combating the 
stigma that continues to surround the experience of living with a dementia (ILC-UK 2014). 
Successfully navigating these turbulent waters can only help to bridge the divide in 
understanding that undoubtedly exists at present.   
 
Study limitations 
There are three main study limitations. Firstly, the patient and family carer sample were 
recruited from a single cancer treatment hospital; therefore, it is not clear whether treatment 
decisions are sometimes made prior to referral to tertiary care. Similarly, it is not clear 
whether similar treatment decisions would have been reached/taken by other hospital sites 
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should the authorship, with more resources, have been able to employ a broader recruitment 
strategy. Secondly, the cross-sectional nature of the study and its design limited the gaining 
of experiences and perspectives over time. Going forward, a more developed longitudinal 
study would provide a more detailed and robust understanding of lived experience that can be 
measured and plotted against significant time points. Thirdly, there was limited ethnic 
diversity in the sample which is not representative of the area in which the data was collected.   
 
Conclusion 
In the most recent Dementia UK report (Alzheimer’s Society 2014a) it was noted under 
Action 12 that dementia research should receive a level of investment that matches the 
economic and human cost of the condition and made the telling observation that dementia 
costs the UK more than cancer, heart disease or diabetes. Despite this, the report pointed out 
that research funding for dementia in the UK was (at that time) £74 million a year, in 
comparison with the £503 million a year spent on cancer. However, one of the issues with 
such binary comparisons is just that, they are binary comparisons and focus on the tragedy of 
inequality rather than on the creativity of solutions. People who live with both dementia and 
cancer often do so with other long-term conditions (such as heart disease) and, if they do not, 
then they live with those two: the cancer that may (or may not) be curable and the dementia 
that is overwhelmingly not. However, the outcome of both experiences is similar: uncertainty 
and a future that is difficult to predict. As the narrative arc in this article has revealed, it is 
simply not possible to divide a person up into their separate diagnostic conditions. Lives and 
illnesses become intertwined and inter-related. Going forward, the research and practice field 
and, arguably, the research funding councils and condition-specific charities, need to come 
together to invest in the whole person, not just in one part in isolation from the rest - however 
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worthy the cause. The lived experience of so many men and women living with a 
combination of  enduring long-term conditions - and their family/support networks - need a 
breakout of commonsense and consensus to occur, and soon. Only then, we would suggest, 
will real progress in evidence-generation and person-centred care and treatment be possible 
and those turbulent waters stilled.   
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